LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/THA Revisions: Dislocation, Pneumonia Are Modifiable Risk Factors
Large Joints and Extremities

THA Revisions: Dislocation, Pneumonia Are Modifiable Risk Factors

May 11, 2020 1 min read Premium comments

Advertisement

THA Revisions: Dislocation, Pneumonia Are Modifiable Risk Factors
Source: Wikimedia Commons Images and Leon Brooks
Secondary#periprostheticfractures#dislocation#hospitalacquiredpneumonia#revisiontha

While there are risks with any surgery, a new study finds that dislocation and hospital-acquired pneumonia are modifiable risk factors associated with mortality in patients who undergo revision total hip arthroplasty for a periprosthetic fracture.

The study, “Modifiable risk factors for mortality in revision total hip arthroplasty for periprosthetic fracture,” was published in the April 2020 issue of The Bone & Joint Journal.

The researchers reviewed the electronic records of consecutive patients undergoing revision THA for periprosthetic hip fracture between December 2011 and October 2018. Data was collected on age, sex, BMI (body mass index), American Society of Anesthesiologists (ASA) classification, the preoperative serum level of hemoglobin, time to surgery, operating time, blood transfusion, length of hospital stay, and postoperative surgical and medical complications.

The records of 203 patients were reviewed. A little more than half of the patients were female and the mean age was 78 years (44 to 100). The median time to surgery was three days (interquartile range, 2 to 55).

The mortality rate at one year was 13.8% (n = 28). And the two most common complications were dislocation (n = 22, 10.8%) and hospital-acquired pneumonia within 80 days of surgery (n = 25, 12%).

According to multivariate analysis, the rate of mortality one year after surgery was five times higher in patients who had a dislocation [OR, 5.03 (95% CI, 1.60 to 15.83); p = 0.006]. The rate of mortality for patients who developed hospital-acquired mortality was four times higher. Time to surgery did not appear to be a risk factor.

The researchers wrote, “This study suggests that surgeons should consider increasing constraint to reduce the risk of dislocation, and the early involvement of a multi-disciplinary team to reduce the risk of hospital-acquired pneumonia. We found no evidence that the time to surgery affected mortality, which may allow time for medical optimization, surgical planning, and resource allocation.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy